Therapy for Stage IV Non–Small-Cell Lung Cancer With Driver Alterations: ASCO Living Guideline, Version 2022.2. Issue 5 (10th February 2023)

• Record Type: Journal Article
• Authors: Owen, Dwight H.; Singh, Navneet; Ismaila, Nofisat; Blanchard, Elizabeth; Celano, Paul; Florez, Narjust; Jain, Dharamvir; Leighl, Natasha B.; Mamdani, Hirva; Masters, Gregory; Moffitt, Pamela R.; Naidoo, Jarushka; Phillips, Tanyanika; Riely, Gregory J.; Robinson, Andrew G.; Schenk, Erin; Schneider, Bryan J.; Sequist, Lecia; Spigel, David R.; Jaiyesimi, Ishmael A.
• Is Part Of: Journal of clinical oncology. Volume 41:Issue 5(2023)
• Page Start: e10
• Page End: e20
• Publication Date: 2023-02-10
• Subjects: Oncology -- Periodicals; Cancer -- Periodicals; Oncology; Medical Oncology; Cancérologie -- Périodiques; Cancer -- Périodiques; Cancérologie; Cancer; Oncology; Oncologia; Càncer; Periodicals; 616.994
• DOI: 10.1200/JCO.22.02124
• Languages: English
• ISSNs: 0732-183X

Abstract

Abstract : Living guidelines are developed for selected topic areas with rapidly evolving evidence that drives frequent change in recommended clinical practice. Living guidelines are updated on a regular schedule by a standing expert panel that systematically reviews the health literature on a continuous basis, as described in the ASCO Guidelines Methodology Manual . ASCO Living Guidelines follow the ASCO Conflict of Interest Policy Implementation for Clinical Practice Guidelines . Living Guidelines and updates are not intended to substitute for independent professional judgment of the treating provider and do not account for individual variation among patients. See Appendix 1 (online only) for disclaimers and other important information. Updates are published regularly and can be found at https://ascopubs.org/nsclc-da-living-guideline .